2010 Portfolio News
News from the portfolios of HBM BioVentures and HBM BioCapital
PTC Therapeutics completes enrollment of Phase 3 trial in Cystic Fibrosis (10 KB)21.12.2010
- Vivacta closes £4 million financing (97 KB)
10.11.2010
- mtm laboratories extends series C financing round by EUR 7 million (USD 9.7 million) (21 KB)
08.11.2010
- Interventional Spine Inc. announces issuance of key patents for the PERPOS PLS System (78 KB)
04.11.2010
- MiCardia corporation receives CE mark clearance to market enCor dynamic mitral valve repair system in te European Union (33 KB)
03.11.2010
- Abbott and Enanta present positive initial results from phase 2 study in Hepatitis C (57 KB)
01.11.2010
- Pivotal data suggest PTC Therapeutics' Ataluren slows loss of walking ability in muscular distrophy patients (47 KB)
15.10.2010
- Interventional Spine, Inc. awarded the 2010 Best New Technology In Cervical Care Award (125 KB)
08.10.2010
- HBM BioVentures sells its investment in Sloning (39 KB)
07.10.2010
- Successful sale of Asthmatx, a company from HBM BioVentures' portfolio, to Boston Scientific increases liquidity by CHF 4 million (37 KB)
21.09.2010
- Nabriva Therapeutic's Pleuromutilin Antibiotic BC-3781 shows therapeutic potential for skin and lung infections with both oral and IV dosing in non-clinical and clinical Phase I studies (33 KB)
10.09.2010
- Vivacta re-aligns management in preparation for £4 million finanacing round (24 KB)
26.08.2010
News
M&A Report
Links
Subscribe To Our Newsletter
Search
© HBM Partners AG 23.02.2012